GeneNews Ltd (TSE:GEN)’s share price reached a new 52-week low during mid-day trading on Monday . The stock traded as low as C$0.04 and last traded at C$0.04, with a volume of 267000 shares changing hands. The stock had previously closed at C$0.04.

WARNING: This story was first posted by Daily Political and is the property of of Daily Political. If you are accessing this story on another publication, it was copied illegally and reposted in violation of international copyright laws. The legal version of this story can be viewed at https://www.dailypolitical.com/2018/11/19/genenews-gen-hits-new-12-month-low-at-0-04.html.

About GeneNews (TSE:GEN)

GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.

Further Reading: Investing strategies using the yield curve

Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.